REQUEST A DEMO
Total
USD $0.00
Search more companies

Mba Pharmaceuticals Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mba Pharmaceuticals Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Mba Pharmaceuticals Private Limited is a company in India, with a head office in Central Delhi. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 26, 2014. There was a net sales revenue increase of 45.1% reported in Mba Pharmaceuticals Private Limited’s latest financial highlights for 2025. Over the same period, its total assets grew by 48.6%. The net profit margin of Mba Pharmaceuticals Private Limited increased by 3.09% in 2025.

Headquarters
4931 Plot No.68 Second Floor South Ansari Road Daryaganj New Dlehi In-Dl In 110002
Central Delhi; Delhi; Postal Code: 110002

Contact Details: Purchase the Mba Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Mba Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Mba Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 26, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Mba Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
45.1%
Total Operating Revenue
43.75%
Operating Profit
471.61%
EBITDA
450.35%
Net Profit/Loss for the Period
9707.34%
Total Assets
48.6%
Total Equity
16.79%
Operating Profit Margin
4.17%
Net Profit Margin
3.09%
Return on Equity (ROE)
14.21%
Debt / Equity
68.66%
Quick Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?